Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma

ABSTRACT:

SUBMITTER: Yan Y 

PROVIDER: S-EPMC4108918 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature